Forteris Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Forteris Wealth Management's BMY Position: Q3 2026 in Review
Forteris Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 5.3% in Q3 2026, selling an estimated $18.1K and leaving 5,074 shares worth $317K. The position accounts for 0.26% of the portfolio, ranked #59.
Forteris Wealth Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. The position peaked at $631K in Q4 2025. 2,542 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Forteris Wealth Management held 5,074 shares of Bristol-Myers Squibb worth $317K as of Q3 2026.
- Forteris Wealth Management sold 286 Bristol-Myers Squibb shares in Q3 2026, an estimated $18.1K.
- Bristol-Myers Squibb made up 0.26% of Forteris Wealth Management's portfolio in Q3 2026, its #59 holding.
- Forteris Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- Forteris Wealth Management's Bristol-Myers Squibb position peaked at $631K in Q4 2025.
- 2,542 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Forteris Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.